Surrozen (SRZN) Cash from Financing Activities (2020 - 2026)

Surrozen (SRZN) recorded quarterly Cash from Financing Activities of $30.3 million in Q1 2026, up 119.72% quarter-over-quarter from $13.8 million in Q4 2025, and down 60.36% on a YoY basis from $76.4 million in Q1 2025.

Surrozen (SRZN) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Surrozen's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $30.3 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 60.36% year-over-year to $30.3 million; the TTM figure through Mar 2026 stood at $38.9 million (down 57.92% YoY), while the FY2025 annual figure was $85.1 million, up 425.79% from the prior year.
  • Cash from Financing Activities was $30.3 million for Q1 2026 at Surrozen, up from $13.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $76.4 million in Q1 2025 to a low of -$5.1 million in Q2 2025.
  • Historically, Cash from Financing Activities has averaged $8.6 million across 5 years, with a median of $9000.0 in 2025.
  • The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities plunged 1703.14% in 2022, then jumped 15043.96% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$2.5 million in 2022, then surged by 105.53% to $141000.0 in 2023, then slumped by 35.46% to $91000.0 in 2024, then surged by 15043.96% to $13.8 million in 2025, then soared by 119.72% to $30.3 million in 2026.
  • The last three Cash from Financing Activities figures came in at $30.3 million (Q1 2026), $13.8 million (Q4 2025), and $9000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 7.00 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 53,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -538.80 Mn
9 Abivax 94.37 Bn 94.37 Bn - 85,464.43
10 Surrozen 225,877.86 -106.68 Mn - 30.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.28 Mn
Mar 31, 2026 30.28 Mn
Dec 31, 2025 13.78 Mn
Dec 31, 2025 13.78 Mn
Sep 30, 2025 9,000.00
Sep 30, 2025 9,000.00
Jun 30, 2025 -5.12 Mn
Jun 30, 2025 -5.12 Mn
Mar 31, 2025 76.39 Mn
Mar 31, 2025 76.39 Mn
Dec 31, 2024 91,000.00
Dec 31, 2024 91,000.00
Sep 30, 2024 -1,000.00
Sep 30, 2024 -1,000.00
Jun 30, 2024 16.09 Mn
Jun 30, 2024 16.09 Mn
Dec 31, 2023 141,000.00
Dec 31, 2023 141,000.00
Sep 30, 2023 -13,000.00
Sep 30, 2023 -13,000.00